APPLICATION
ANDA218024
TYPE
ANDA
ORIGINAL APPROVAL
2023-10-24
LATEST ACTION
2023-10-24
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Prescription
Products
SUNITINIB MALATEPrescription
SUNITINIB MALATE EQ 37.5MG BASE · CAPSULE · ORAL
SUNITINIB MALATEPrescription
SUNITINIB MALATE EQ 12.5MG BASE · CAPSULE · ORAL
SUNITINIB MALATEPrescription
SUNITINIB MALATE EQ 50MG BASE · CAPSULE · ORAL
SUNITINIB MALATEPrescription
SUNITINIB MALATE EQ 25MG BASE · CAPSULE · ORAL
Approval history
2023-10-24UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.